Banner
References
Paralisi cerebrale infantile: tossina botulinica nel trattamento del piede equino
published in May - June 2004 - in Il Fisioterapista - issue n.3

There are no translations available.

Bibliografia

  1. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999; 6 (suppl. 4): 23-35.

  2. Boyd RN, Hays RM. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 2001; 8 (suppl. 5): 1-20.

  3. Galli M, Fazzi E, Motta F, Crivellini M. Kinematic and dynamic analysis of the ankle joint in children with cerebral palsy. Funct Neurol 1999; 14(3): 135-40.

  4. Koman LA, Mooney III JF, Smith B, Goodman A. Management of cerebral palsy with botulinum toxin A: preliminary investigation. J Pediatr Orthop 1993; 13: 489-95.

  5. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998; 18(3): 304-11.

  6. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386-96.

  7. Graham HK, Aoki KR, Autti-Ramo I et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11(1): 67-79.

  8. Koman LA, Mooney JF, Smith BP, Goodman A. Management of spasticity of cerebral palsy with botulinum A toxin: a report of preliminary, randomized, double blind trial. J Pediatr Orthop 1994; 14: 229-303.

  9. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 1996; 4: 269-79.

  10. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double blind study of botulinum toxin A injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999; 10(1): 1-9.

  11. Davis RB, Ounpuu S, Tyburski DJ, Gage JR. A gait analysis data collection and reduction technique. Hum Mov Sci 1991; 10: 575-87.

  12. Autti-Raemoe I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol 2001; 8 (suppl.5): 136-44.

  13. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol 2001; 8 (suppl. 5): 150-66.

  14. Chambers HG. Treatment of functional limitation at the knee in ambulatory children with cerebral palsy. Eur J Neurol 2001; 8 (suppl. 5): 59-74.


 
There are no translations available.